[	O
Diagnostic	O
value	O
of	O
DNA	O
,	O
RNA	O
and	O
proliferating	O
cell	O
nuclear	O
antigen	O
examination	O
in	O
malignant	B-Organism_substance
pleural	I-Organism_substance
effusions	I-Organism_substance
by	O
flow	O
cytometry	O
]	O
.	O

OBJECTIVE	O
:	O

To	O
study	O
the	O
diagnostic	O
value	O
of	O
DNA	O
,	O
RNA	O
and	O
proliferating	O
cell	O
nuclear	O
antigen	O
(	O
PCNA	O
)	O
examination	O
in	O
malignant	B-Organism_substance
effusion	I-Organism_substance
by	O
multiparametric	O
flow	O
cytometry	O
,	O
and	O
therefore	O
to	O
provide	O
proof	O
for	O
clinical	O
application	O
.	O

METHODS	O
:	O

Forty	O
seven	O
patients	O
with	O
pleural	B-Organism_substance
effusions	I-Organism_substance
in	O
our	O
hospital	O
from	O
August	O
2003	O
to	O
February	O
2004	O
were	O
divided	O
into	O
two	O
groups	O
:	O
19	O
suffering	O
from	O
benign	B-Organism_substance
pleural	I-Organism_substance
effusions	I-Organism_substance
and	O
28	O
from	O
malignant	B-Organism_substance
effusions	I-Organism_substance
confirmed	O
by	O
pathologic	O
examination	O
.	O

The	O
cells	B-Cell
for	O
diagnosis	O
were	O
divided	O
into	O
four	O
groups	O
stained	O
by	O
PI	O
(	O
Propidium	O
-	O
iodide	O
)	O
,	O
PY	O
(	O
Pyronin	O
)	O
,	O
PCNA	O
-	O
FITC	O
and	O
PCNA	O
-	O
mouse	O
-	O
alpha	O
-	O
2a	O
.	O

The	O
specimens	B-Organism_substance
were	O
analyzed	O
by	O
a	O
flow	O
cytometer	O
(	O
FacS	O
Caliber	O
,	O
Becton	O
Dickinson	O
)	O
.	O

The	O
sensitivity	O
and	O
the	O
specificity	O
of	O
each	O
examination	O
and	O
combined	O
examination	O
were	O
calculated	O
by	O
statistic	O
software	O
SPSS	O
13	O
.	O
0	O
.	O

RESULTS	O
:	O

(	O
1	O
)	O
The	O
expression	O
of	O
DI	O
,	O
RI	O
,	O
and	O
PI	O
in	O
benign	B-Organism_substance
pleural	I-Organism_substance
effusion	I-Organism_substance
was	O
1	O
.	O
03	O
+	O
/	O
-	O
0	O
.	O
06	O
,	O
10	O
.	O
03	O
+	O
/	O
-	O
0	O
.	O
54	O
,	O
and	O
(	O
4	O
.	O
86	O
+	O
/	O
-	O
0	O
.	O
72	O
)	O
%	O
,	O
respectively	O
,	O
and	O
those	O
in	O
malignant	B-Organism_substance
ones	I-Organism_substance
was	O
1	O
.	O
26	O
+	O
/	O
-	O
0	O
.	O
17	O
,	O
11	O
.	O
65	O
+	O
/	O
-	O
1	O
.	O
45	O
,	O
and	O
(	O
11	O
.	O
97	O
+	O
/	O
-	O
1	O
.	O
50	O
)	O
%	O
,	O
respectively	O
,	O
the	O
difference	O
being	O
statistically	O
significant	O
.	O

The	O
cutoff	O
value	O
of	O
DI	O
,	O
RI	O
and	O
PI	O
was	O
1	O
.	O
10	O
%	O
,	O
10	O
.	O
75	O
%	O
and	O
4	O
.	O
56	O
%	O
,	O
and	O
the	O
sensitivity	O
of	O
DI	O
examination	O
was	O
89	O
.	O
3	O
%	O
,	O
78	O
.	O
6	O
%	O
,	O
75	O
.	O
0	O
%	O
,	O
and	O
the	O
specificity	O
was	O
89	O
.	O
5	O
%	O
,	O
98	O
.	O
5	O
%	O
,	O
84	O
.	O
2	O
%	O
,	O
respectively	O
.	O

(	O
2	O
)	O
In	O
6	O
cases	O
suffering	O
from	O
malignant	B-Organism_substance
pleural	I-Organism_substance
effusions	I-Organism_substance
,	O
RI	O
was	O
positive	O
but	O
DI	O
was	O
negative	O
,	O
indicating	O
that	O
DI	O
combined	O
with	O
RI	O
examination	O
was	O
better	O
than	O
DI	O
examination	O
alone	O
.	O

(	O
3	O
)	O
In	O
5	O
cases	O
suffering	O
from	O
malignant	B-Organism_substance
pleural	I-Organism_substance
effusions	I-Organism_substance
confirmed	O
by	O
tissue	B-Tissue
examination	O
,	O
the	O
cytology	O
was	O
negative	O
,	O
but	O
the	O
result	O
of	O
DI	O
and	O
RI	O
was	O
abnormal	O
,	O
indicating	O
that	O
flow	O
cytometry	O
was	O
complementary	O
to	O
pathologic	O
examination	O
.	O

(	O
4	O
)	O
The	O
sensitivity	O
of	O
DI	O
+	O
RI	O
,	O
DI	O
+	O
PI	O
,	O
RI	O
+	O
PI	O
and	O
DI	O
+	O
RI	O
+	O
PI	O
combined	O
examination	O
was	O
98	O
.	O
2	O
%	O
,	O
89	O
.	O
3	O
%	O
,	O
89	O
.	O
3	O
%	O
,	O
92	O
.	O
9	O
%	O
;	O
the	O
specificity	O
was	O
84	O
.	O
2	O
%	O
,	O
89	O
.	O
5	O
%	O
,	O
84	O
.	O
2	O
%	O
,	O
94	O
.	O
2	O
%	O
respectively	O
.	O

The	O
results	O
demonstrated	O
that	O
DI	O
+	O
RI	O
+	O
PI	O
combined	O
examination	O
was	O
the	O
best	O
,	O
which	O
showed	O
the	O
least	O
false	O
negative	O
and	O
false	O
positive	O
results	O
.	O

The	O
sensitivity	O
of	O
DI	O
+	O
RI	O
combined	O
examination	O
was	O
98	O
.	O
2	O
%	O
,	O
but	O
the	O
specificity	O
was	O
84	O
.	O
2	O
%	O
,	O
the	O
false	O
positive	O
rate	O
being	O
higher	O
than	O
DI	O
+	O
RI	O
+	O
PI	O
combined	O
examination	O
.	O

In	O
none	O
of	O
the	O
benign	B-Organism_substance
pleural	I-Organism_substance
effusions	I-Organism_substance
was	O
the	O
DI	O
+	O
RI	O
+	O
PI	O
higher	O
than	O
the	O
cutoff	O
value	O
,	O
suggesting	O
that	O
combined	O
examination	O
can	O
exclude	O
benign	B-Organism_substance
pleural	I-Organism_substance
effusions	I-Organism_substance
.	O

CONCLUSIONS	O
:	O

DNA	O
,	O
RNA	O
and	O
PCNA	O
examinations	O
by	O
flow	O
cytometry	O
are	O
of	O
value	O
in	O
the	O
diagnosis	O
of	O
malignant	B-Organism_substance
effusion	I-Organism_substance
,	O
especially	O
for	O
cases	O
which	O
can	O
not	O
be	O
diagnosed	O
by	O
cytological	O
examination	O
.	O

DI	O
+	O
RI	O
+	O
PI	O
combined	O
examination	O
showed	O
better	O
results	O
with	O
the	O
lowest	O
false	O
negative	O
and	O
false	O
positive	O
rates	O
.	O

